1 not yet recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Hip Fracture Surgery: new trials by email Literature Review of Hip Fracture Surgery trials Research Report on Hip Fracture Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention rivaroxaban and ASA, Low-molecular weight heparin, Fondaparinux - Hip Fracture Surgery, Cardiovascular Prevention | Phase 3 | Not yet recruiting | McMaster University | 100 | 2025-12-01 | 2025-11-14 |
| A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery Heparin Sodium - Eurofarma, Heparin Sodium - APP Pharmaceuticals - Hip Fracture Surgery | Phase 3 | Terminated | Eurofarma Laboratorios S.A. | 544 | 2011-10-01 | 2012-10-16 |
Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Thromboembolism (1) · Vascular Diseases (1)
Aspirin (1) · Dalteparin (1) · Enoxaparin (1) · Fondaparinux (1) · N(4)-oleylcytosine arabinoside (1) · Rivaroxaban (1) · Tinzaparin (1) · apixaban (1)
Eurofarma Laboratorios S.A. (1) · McMaster University (1)
Brazil (1) · Canada (1) · Italy (1)